Efficacy and safety study of the antihistamine V0114CP 2.5MG tablet in the treatment of seasonal allergic rhinitis. A randomised, double blind, placebo controlled study
Efficacy and safety study of the antihistamine V0114CP 2.5MG tablet in the treatment of seasonal allergic rhinitis. A randomised, double blind, placebo controlled study
Efficacy and safety study of the antihistamine V0114CP 2.5MG tablet in the treatment of seasonal allergic rhinitis. A randomised, double blind, placebo controlled study
Status
Status :
Completed
Type of study
Phase III
Min. Age
18
Years old
Max. Age
-
Gender
All
Therapeutic area :
Allergy
Disease :
Allergic rhinitis
Study medication :
L-mequitazine (Xyzall®)
Phase :
Phase III
Start Date :
25 April 2007
End date :
25 July 2007
Study ID :
V00114 CP 301 2A
EudraCT/CTIS number :
2006-006947-30
Send by email